These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7190432)

  • 1. Cefamandole: pharmacokinetics and therapeutic evaluation in urology.
    Zinati AH; Naber KG
    Arzneimittelforschung; 1980; 30(5):839-42. PubMed ID: 7190432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cefamandole: in vitro and in vivo activity].
    Martinetto P; Valtz A; Cavallo GP; Angeretti A
    G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies with cefazedone.
    Primavesi CA
    Arzneimittelforschung; 1979; 29(2a):381-4. PubMed ID: 582713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of urologic infections with cefamandole (Pharmachim)--the microbiological and clinical results].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1986; 25(4):32-8. PubMed ID: 3765588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
    Hautmann R; Pranada F; Ahlert G
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
    Ohkawa M; Hirano S; Nakashima T; Tokunaga S; Motoi I; Kuroda K; Nakamura T; Iwasa Y; Tajika E; Sakai A; Haginaka T; Kanda S; Kato M; Hasegawa M; Mikawa I; Ikeda A; Shoda R; Ejiri S; Takemae K; Kojima A; Nakajima S; Miyagi T; Ohtaki M; Kitagawa K; Kameda K; Taya T; Okumura R; Shimada K; Kobayashi T; Nango C; Okasho A; Fujita Y; Miyazaki K; Tsukahara K; Kawaguchi S; Tanaka T; Ueno K; Watanabe K
    Jpn J Antibiot; 1983 Jan; 36(1):129-49. PubMed ID: 6341653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally active esters of cephalosporin antibiotics. 3. Synthesis and biological properties of aminoacyloxymethyl esters of 7-[D(-)-mandelamido]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-3-cephem-4-carboxylic acid.
    Wheeler WJ; Preston DA; Wright WE; Huffman GW; Osborne HE; Howard DP
    J Med Chem; 1979 Jun; 22(6):657-61. PubMed ID: 379336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with cefamandole in bacterial infections of children (author's transl)].
    Ichioka T; Miyao M
    Jpn J Antibiot; 1979 Sep; 32(9):901-4. PubMed ID: 501918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceforanide kinetics.
    Estey EH; Weaver SS; LeBlanc BM; Brown N; Ho DH; Bodey GP
    Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
    Fraser DG
    Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug trials: treatment of urinary tract infection with multiple-dose intramuscular administration of cephamandole.
    Nankervis A; Fairley KF; Shaw P; Whitworth JA; Miles H; Graham I; Pavillard R
    Med J Aust; 1980 May; 1(9):427-8. PubMed ID: 7393095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.